Published in Am J Hum Genet on July 01, 1996
Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. J Mol Biol (2006) 1.59
Characterization of the Glu and Asp residues in the active site of human beta-hexosaminidase B. Biochemistry (2001) 1.00
Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase. Biochemistry (2001) 0.95
Role of beta Arg211 in the active site of human beta-hexosaminidase B. Biochemistry (2000) 0.85
Assessing the severity of the small inframe deletion mutation in the alpha-subunit of beta-hexosaminidase A found in the Turkish population by reproducing it in the more stable beta-subunit. J Inherit Metab Dis (2004) 0.81
Variation of beta-N-acetylhexosaminidase-pattern in Tay-Sachs disease. FEBS Lett (1969) 2.49
Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet (1992) 2.12
Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem (1971) 2.11
The subunit and polypeptide structure of hexosaminidases from human placenta. Can J Biochem (1980) 1.86
Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. J Biol Chem (1985) 1.66
Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics (1991) 1.57
The presence of two different infantile Tay-Sachs disease mutations in a Cajun population. Am J Hum Genet (1992) 1.39
Mutation in GM2-gangliosidosis B1 variant. J Neurochem (1988) 1.37
Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A. Biochemistry (1996) 1.23
The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis. Biochim Biophys Acta (1991) 1.22
A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis. Am J Hum Genet (1992) 1.21
Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity. J Biol Chem (1989) 1.12
The lysosomal hexosaminidase isozymes. Isozymes Curr Top Biol Med Res (1985) 1.08
Overexpression rescues the mutant phenotype of L176F mutation causing beta-glucuronidase deficiency mucopolysaccharidosis in two Mennonite siblings. J Biol Chem (1994) 1.05
A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation. Hum Mol Genet (1992) 1.02
A double mutation in exon 6 of the beta-hexosaminidase alpha subunit in a patient with the B1 variant of Tay-Sachs disease. Am J Hum Genet (1992) 0.98
Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease. J Biol Chem (1991) 0.98
Tay-Sachs disease: B1 variant. Pediatr Neurol (1989) 0.88
Preferential beta-hexosaminidase (Hex) A (alpha beta) formation in the absence of beta-Hex B (beta beta) due to heterozygous point mutations present in beta-Hex beta-chain alleles of a motor neuron disease patient. J Biol Chem (1994) 0.81
Molecular characterization of both alleles in an unusual Tay-Sachs disease B1 variant. Am J Hum Genet (1994) 0.79
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1993) 5.14
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Isolation of cDNA clones coding for the beta subunit of human beta-hexosaminidase. Proc Natl Acad Sci U S A (1985) 3.50
Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med (1991) 3.39
Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation (1997) 3.27
Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes. Proc Natl Acad Sci U S A (1986) 3.21
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost (1993) 3.12
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem (1986) 2.54
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 2.32
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet (1974) 2.29
Detailed alignment of saccharum and sorghum chromosomes: comparative organization of closely related diploid and polyploid genomes. Genetics (1998) 2.24
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation (1999) 2.08
ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost (1989) 1.86
Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med (1990) 1.78
Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (2001) 1.73
What young people think and do when the option for cystic fibrosis carrier testing is available. J Med Genet (1993) 1.68
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Characterization of the human HEXB gene encoding lysosomal beta-hexosaminidase. Genomics (1988) 1.60
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci U S A (1999) 1.60
Actin filaments participate in the relocalization of phosphatidylinositol3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes. Biochem J (1998) 1.57
Water immersion versus standard colonoscopy insertion technique: randomized trial shows promise for minimal sedation. Endoscopy (2010) 1.56
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation (1999) 1.49
Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura. Lancet (1981) 1.49
Ligand affinity of the 67-kD elastin/laminin binding protein is modulated by the protein's lectin domain: visualization of elastin/laminin-receptor complexes with gold-tagged ligands. J Cell Biol (1991) 1.48
State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation (2001) 1.47
Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun (1994) 1.44
Cytotoxicity of carbobenzoxy-protected amino acids. In Vitro Cell Dev Biol (1992) 1.41
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis (1991) 1.40
The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem (1998) 1.36
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes. Clin Chim Acta (1984) 1.27
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res (2001) 1.25
Metastatic tumors of the hand: a report of six cases. J Hand Surg Am (1978) 1.24
Secretion of proteoglycans by chondrocytes. Influence of colchicine, cytochalasin B, and beta-D-xyloside. Arch Biochem Biophys (1979) 1.24
The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. J Biol Chem (1989) 1.24
beta-Hexosaminidase isozymes from cells cotransfected with alpha and beta cDNA constructs: analysis of the alpha-subunit missense mutation associated with the adult form of Tay-Sachs disease. Am J Hum Genet (1993) 1.24
Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A. Biochemistry (1996) 1.23
A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis. Am J Hum Genet (1992) 1.21
Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res (1995) 1.20
Increased platelet aggregates in patients with transient ischemic attacks. Stroke (1975) 1.20
Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). J Biol Chem (1986) 1.18
Cell cycle-dependent regulation of eukaryotic DNA methylase level. J Biol Chem (1985) 1.17
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care (1999) 1.16
A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease. J Biol Chem (1998) 1.15
Aspirin and salicylate: An old remedy with a new twist. Circulation (2000) 1.15
Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB. Pediatr Res (1982) 1.15
Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein. Biochemistry (1989) 1.14
Fallibility of the clinical diagnosis of venous thrombosis. JAMA (1975) 1.14
Purification and properties of a diketo acid hydrolase from beef liver. Biochemistry (1972) 1.13
Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity. J Biol Chem (1989) 1.12
Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem (2001) 1.12
Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay. Biochim Biophys Acta (1997) 1.11
DNA methylation pattern is determined by the intracellular level of the methylase. Proc Natl Acad Sci U S A (1984) 1.11
Evidence for two dissimilar polypeptide chains in the beta 2 subunit of hexosaminidase. Proc Natl Acad Sci U S A (1982) 1.11
Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun (1995) 1.10
The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest (1994) 1.09
Cloning and expression of rat histidase. Homology to two bacterial histidases and four phenylalanine ammonia-lyases. J Biol Chem (1990) 1.09
Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb (1993) 1.08
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb (1993) 1.08
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thromb Haemost (1976) 1.06
Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity. J Biol Chem (1994) 1.06
Smoking cessation among Hong Kong Chinese smokers attending hospital as outpatients: impact of doctors' advice, successful quitting and intention to quit. Asia Pac J Public Health (2004) 1.06
Cystic fibrosis carrier screening by DNA analysis: a pilot study of attitudes among participants. Am J Hum Genet (1991) 1.05
Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation (1995) 1.05
Adult onset motor neuronopathy in the juvenile type of hexosaminidase A and B deficiency. J Neurol Sci (1988) 1.03
Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase. J Clin Invest (1988) 1.03
Metastatic tumors of the foot. South Med J (1978) 1.02
Purification and properties of the hexosaminidase A-activating protein from human liver. Biochem J (1977) 1.02
Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis. Biochem J (2000) 1.02
A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation. Hum Mol Genet (1992) 1.02
An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds. J Clin Invest (1992) 1.01
Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells. J Biol Chem (2000) 1.01
Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med (1978) 1.00
Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem (1996) 1.00
Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma /Janus kinase 2/MEK-1-dependent pathway. J Biol Chem (2001) 1.00
Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec (1989) 1.00
Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A. Can J Biochem (1977) 0.99
More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians. Am J Hum Genet (1990) 0.99
Improved concanavalin A-Sepharose elution by specific readsorption of glycoproteins. J Chromatogr (1983) 0.99
Development of immunoreagents to ciliary zonules that react with protein components of elastic fiber microfibrils and with elastin-producing cells. Biochem Biophys Res Commun (1988) 0.99
Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. J Clin Invest (1990) 0.99
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost (1994) 0.98
Neutrophils show chemotaxis to type IV collagen and its 7S domain and contain a 67 kD type IV collagen binding protein with lectin properties. Am J Respir Cell Mol Biol (1989) 0.98
Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease. J Biol Chem (1991) 0.98
Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem (1995) 0.97
Characterization of polypeptides serologically and structurally related to hexosaminidase in cultured fibroblasts. J Clin Invest (1983) 0.97
Characterization and substrate specificity of fumarylacetoacetate fumarylhydrolase. Can J Biochem (1977) 0.97
Kinetics of receptor-mediated binding of tropoelastin to ligament fibroblasts. J Biol Chem (1988) 0.96
Characterization of the roles of the 594-645 region in human endothelial nitric-oxide synthase in regulating calmodulin binding and electron transfer. J Biol Chem (2000) 0.96
Soluble thrombomodulin as predictor of incident coronary heart disease. Lancet (1999) 0.96
Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation (2000) 0.96
Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis (1992) 0.96
Structure of the GM2A gene: identification of an exon 2 nonsense mutation and a naturally occurring transcript with an in-frame deletion of exon 2. Am J Hum Genet (1999) 0.96
Translation initiation in the HEXB gene encoding the beta-subunit of human beta-hexosaminidase. J Biol Chem (1990) 0.96
Detection of deep vein thrombosis with an automatic electrically calibrated strain gauge plethysmograph. Surgery (1977) 0.95